Experimental Study: Interleukin-31 Augments Morphine-Induced Antinociceptive Activity and Suppress Tolerance Development in Mice

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2023 Nov 25

PMID 38003738

Authors

Iwao Arai

Minoru Tsuji

Saburo Saito

Hiroshi Takeda

Affiliations

Soon will be listed here.

Abstract

Morphine-induced antinociception is partially reduced in interleukin-31 (IL-31) receptor A (IL-31RA)-deficient mice, indicating that IL-31RA is crucial for morphine-induced peripheral antinociception. Herein, we examined the combined effects of IL-31 and morphine on the antinociceptive activity and itch-associated scratching behavior (LLS) in mice and elucidated the regulatory mechanisms. A hot-plate test was used to assess antinociception. LLS was automatically detected and recorded via a computer. IL-31RA mRNA expression was assessed using real-time polymerase chain reaction. Repeated pre-treatment with IL-31 resulted in significant antinociceptive activity. Repeated administration of morphine decreased the morphine-induced antinociceptive activity, LLS counts, and regular dose and inhibited IL-31-induced LLS. These results suggested that the repeated administration of morphine depleted inter-neuronal IL-31RA levels, preventing morphine-induced antinociception. Therefore, IL-31 may be helpful as an adjunct analgesic to morphine. To explore the benefits of IL-31, its influence on morphine-induced antinociceptive tolerance in mice was examined. An IL-31 and morphine combination increased the analgesic action, which increased the expression of DRG neuronal IL-31RA, elucidating the site of peripheral antinociception of morphine. This site may induce exocytosis of IL-31RA in the sensory nervous system. Collectively, the suppressive effect of IL-31 on morphine-induced antinociceptive tolerance may result from IL-31RA supplementation in sensory nerves.

References

Mansour A, Fox C, Thompson R, Akil H, Watson S . mu-Opioid receptor mRNA expression in the rat CNS: comparison to mu-receptor binding. Brain Res. 1994; 643(1-2):245-65. DOI: 10.1016/0006-8993(94)90031-0. View

Obara I, Gunduz Cinar O, Starowicz K, Benyhe S, Borsodi A, Przewlocka B . Agonist-dependent attenuation of mu-opioid receptor-mediated G-protein activation in the dorsal root ganglia of neuropathic rats. J Neural Transm (Vienna). 2010; 117(4):421-9. DOI: 10.1007/s00702-010-0382-y. View

Eddy N, Leimbach D . Synthetic analgesics. II. Dithienylbutenyl- and dithienylbutylamines. J Pharmacol Exp Ther. 1953; 107(3):385-93. View

Sonkoly E, Muller A, Lauerma A, Pivarcsi A, Soto H, Kemeny L . IL-31: a new link between T cells and pruritus in atopic skin inflammation. J Allergy Clin Immunol. 2006; 117(2):411-7. DOI: 10.1016/j.jaci.2005.10.033. View

Onigbogi O, Ajayi A, Ukponmwan O . Mechanisms of chloroquine-induced body-scratching behavior in rats: evidence of involvement of endogenous opioid peptides. Pharmacol Biochem Behav. 2000; 65(2):333-7. DOI: 10.1016/s0091-3057(99)00221-x. View

Sanchez E, Bagues A, Martin M . Contributions of peripheral and central opioid receptors to antinociception in rat muscle pain models. Pharmacol Biochem Behav. 2010; 96(4):488-95. DOI: 10.1016/j.pbb.2010.07.009. View

Takaoka A, Arai I, Sugimoto M, Yamaguchi A, Tanaka M, Nakaike S . Expression of IL-31 gene transcripts in NC/Nga mice with atopic dermatitis. Eur J Pharmacol. 2005; 516(2):180-1. DOI: 10.1016/j.ejphar.2005.04.040. View

Furlan A, Sandoval J, Mailis-Gagnon A, Tunks E . Opioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects. CMAJ. 2006; 174(11):1589-94. PMC: 1459894. DOI: 10.1503/cmaj.051528. View

Dillon S, Sprecher C, Hammond A, Bilsborough J, Rosenfeld-Franklin M, Presnell S . Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice. Nat Immunol. 2004; 5(7):752-60. DOI: 10.1038/ni1084. View

10.

Ikoma A, Rukwied R, Stander S, Steinhoff M, Miyachi Y, Schmelz M . Neuronal sensitization for histamine-induced itch in lesional skin of patients with atopic dermatitis. Arch Dermatol. 2003; 139(11):1455-8. DOI: 10.1001/archderm.139.11.1455. View

11.

Spanagel R, Herz A, Shippenberg T . Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. Proc Natl Acad Sci U S A. 1992; 89(6):2046-50. PMC: 48593. DOI: 10.1073/pnas.89.6.2046. View

12.

Cevikbas F, Wang X, Akiyama T, Kempkes C, Savinko T, Antal A . A sensory neuron-expressed IL-31 receptor mediates T helper cell-dependent itch: Involvement of TRPV1 and TRPA1. J Allergy Clin Immunol. 2013; 133(2):448-60. PMC: 3960328. DOI: 10.1016/j.jaci.2013.10.048. View

13.

Loh H, Liu H, Cavalli A, Yang W, Chen Y, Wei L . mu Opioid receptor knockout in mice: effects on ligand-induced analgesia and morphine lethality. Brain Res Mol Brain Res. 1998; 54(2):321-6. DOI: 10.1016/s0169-328x(97)00353-7. View

14.

Zech D, Grond S, Lynch J, Hertel D, Lehmann K . Validation of World Health Organization Guidelines for cancer pain relief: a 10-year prospective study. Pain. 1995; 63(1):65-76. DOI: 10.1016/0304-3959(95)00017-M. View

15.

Sora I, Takahashi N, Funada M, Ujike H, Revay R, Donovan D . Opiate receptor knockout mice define mu receptor roles in endogenous nociceptive responses and morphine-induced analgesia. Proc Natl Acad Sci U S A. 1997; 94(4):1544-9. PMC: 19828. DOI: 10.1073/pnas.94.4.1544. View

16.

Kasai S, Hayashida M, Sora I, Ikeda K . Candidate gene polymorphisms predicting individual sensitivity to opioids. Naunyn Schmiedebergs Arch Pharmacol. 2007; 377(4-6):269-81. DOI: 10.1007/s00210-007-0205-3. View

17.

Arai I, Tsuji M, Miyagawa K, Takeda H, Akiyama N, Saito S . Repeated administration of IL-31 upregulates IL-31 receptor A (IL-31RA) in dorsal root ganglia and causes severe itch-associated scratching behaviour in mice. Exp Dermatol. 2014; 24(1):75-8. DOI: 10.1111/exd.12587. View

18.

Kuraishi Y, Harada Y, ARATANI S, Satoh M, Takagi H . Separate involvement of the spinal noradrenergic and serotonergic systems in morphine analgesia: the differences in mechanical and thermal algesic tests. Brain Res. 1983; 273(2):245-52. DOI: 10.1016/0006-8993(83)90849-1. View

19.

Sikand P, Shimada S, Green B, LaMotte R . Sensory responses to injection and punctate application of capsaicin and histamine to the skin. Pain. 2011; 152(11):2485-2494. PMC: 3199342. DOI: 10.1016/j.pain.2011.06.001. View

20.

Ikeda K, Kobayashi T, Ichikawa T, Kumanishi T, Niki H, Yano R . The untranslated region of (mu)-opioid receptor mRNA contributes to reduced opioid sensitivity in CXBK mice. J Neurosci. 2001; 21(4):1334-9. PMC: 6762225. View